EMULATE
Emulate is a privately held company that creates advanced in vitro models for understanding how diseases, medicines, chemicals, and foods affect human health.
EMULATE
Industry:
Biotechnology Health Care Life Science Medical
Founded:
2013-01-01
Address:
Boston, Massachusetts, United States
Country:
United States
Website Url:
http://www.emulatebio.com
Total Employee:
51+
Status:
Active
Contact:
+1 781 583 3515
Email Addresses:
[email protected]
Total Funding:
224.27 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
Aulos Bioscience
Aulos Bioscience is dedicated to revolutionizing patient care in cancer with highly differentiated immuno-oncology therapeutics.
Novellus
Novellus is a biotechnology company working to develop engineered cellular medicines.
Ontera
Ontera develops a hand-held point of use diagnostic platform that examines DNA and RNA, and analytes from any life form.
Redcliffe Labs
Redcliffe is a one-stop diagnostic platform offering a wide selection of tests to choose from and delivering care closer to the customer.
Surface Oncology
Surface Oncology develops next-generation cancer immunotherapy treatments based on proprietary discoveries.
Voyager Therapeutics
Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.
Current Advisors List
Current Employees Featured
Founder
Investors List
Northpond Ventures
Northpond Ventures investment in Series E - Emulate
Perceptive Advisors
Perceptive Advisors investment in Series E - Emulate
Alumni Ventures
Alumni Ventures investment in Debt Financing - Emulate
Founders Fund
Founders Fund investment in Series D - Emulate
Northpond Ventures
Northpond Ventures investment in Series D - Emulate
Alumni Ventures
Alumni Ventures investment in Series D - Emulate
Ethos Family Office
Ethos Family Office investment in Venture Round - Emulate
Glass Wall Syndicate
Glass Wall Syndicate investment in Series C - Emulate
Starlight Ventures
Starlight Ventures investment in Series C - Emulate
ALS Investment Fund
ALS Investment Fund investment in Series C - Emulate
Official Site Inspections
http://www.emulatebio.com Semrush global rank: 1.55 M Semrush visits lastest month: 16.94 K
- Host name: 141.193.213.10
- IP address: 141.193.213.10
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Emulate"
Emulate - Wikipedia
Emulate, Inc. (Emulate) is a biotechnology company that commercialized Organs-on-Chips technology—a human cell-based technology that recreates organ-level function to model …See details»
Emulate 2025 Company Profile: Valuation, Funding
Information on valuation, funding, cap tables, investors, and executives for …See details»
Emulate - Crunchbase Company Profile & Funding
Emulate creates advanced in vitro models for understanding how diseases, …See details»
Emulate, Inc. - MassBio
At Emulate, we understand that animal studies and reductionist models are limited because they are not based on integrated human biology. By leveraging 21st century technologies, we are …See details»
Emulate Company Profile - American Pharmaceutical …
Emulate is igniting a new era in human health with industry- leading Organ-on-a-Chip technology. The Human Emulation System provides a window into the …See details»
Emulate - Company info. interviews, news - BiopharmaTrend
Jan 25, 2024 Founded in 2013, Emulate is a Boston-based company developing organ-on-a-chip systems for various research and drug discovery purposes. By now, they …See details»
Emulate – Overview – Funding, Revenue & Growth – 2025
Emulate Revenue & Valuation Emulate's operations are expected to yield yearly revenues near $39.7M. This translates to an estimated $193.8K in revenue per employee for Emulate. Across …See details»
About Us | Global Leader in Organ-on-a-Chip …
Emulate is leveraging Organ-on-a-Chip technology to ignite a new era in human health. Learn about our company and team.See details»
Emulate - Work in biotech
Emulate is developing Organs-on-Chips technology to understand human diseases. By emulating human biology, Emulate is using the power of Organs-on-Chips to generate in vitro models …See details»
Emulate’s Competitors, Revenue, Number of Employees, Funding …
Emulate’s Profile, Revenue and Employees. Emulate is a Massachusetts-based company that develops Organs-on-Chips platform that emulates and recreates the organ-level functions in …See details»
Comprehensive Overview of Emulate Bio: Company Profile and …
Oct 29, 2024 Emulate, Inc., also known as Emulate Bio, is a biotechnology company headquartered in Boston, Massachusetts, United States. The company specializes in …See details»
Emulate, Inc. - CMOCRO
Emulate Inc. is a privately held company that creates living products for understanding how diseases, medicines, chemicals, and foods affect human health. Company\\'s lab-ready …See details»
Emulate Contact Information | Biocompare.com
Emulate, a pioneering Organ-Chip company, is dedicated to overcoming the limitations of traditional animal studies and reductionist models in life science research.See details»
Advance Your Career at Emulate
We invest equally in our team members, have programs in place to raise cultural awareness, and partner with organizations in the communities we live and work to raise awareness and foster …See details»
Emulate Closes $82 Million Series E Financing to Scale Amid Rapid ...
Sep 7, 2021 For more information on Emulate, please visit emulatebio.com About Emulate Emulate is igniting a new era in human health with industry leading organ-on-a-chip technology.See details»
Emulate Announces Organ-on-a-Chip Application and Services …
Jan 8, 2021 To learn more about Emulate Organ-Chips, visit emulatebio.com. About Emulate, Inc. Emulate Inc. is a privately held company that creates advanced in vitro models for …See details»
Emulate | Science Company | Labroots
Oct 15, 2020 Emulate's Organ-on-Chips technology sets a new standard for recreating true-to-life human biology and is now being used to advance product innovation, design, and safety …See details»
Emulate Closes $82 Million Series E Financing to Scale Amid Rapid ...
Sep 7, 2021 Company plans to expand research and development and scale commercial organization to support global customer base BOSTON, MA — September 7, 2021 — …See details»
Biotech Startup Tahoe Therapeutics Raised $30 Million To Build AI ...
1 day ago The Palo Alto, California-based company, now valued at $120 million, has developed a scalable way to quickly generate crucial biological data needed for AI models–and use them …See details»
Zoë-CM2 Culture Module | Emulate
Advanced cell culture system for disease research and drug development, including Organ-Chips, hardware, and software applications.See details»